MedPacto, Inc. (KOSDAQ: 235980)
South Korea
· Delayed Price · Currency is KRW 6,170.00
+300.00 (5.11%)
Oct 11, 2024, 9:00 AM KST
MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 207.19 billion. The enterprise value is 147.02 billion.
| Market Cap | 207.19B |
| Enterprise Value | 147.02B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 33.58 million shares outstanding. The number of shares has decreased by -17.66% in one year.
| Shares Outstanding | 33.58M |
| Shares Change (YoY) | -17.66% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.43% |
| Owned by Institutions (%) | 6.37% |
| Float | 24.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.30 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.84 |
Financial Position
The company has a current ratio of 8.14
| Current Ratio | 8.14 |
| Quick Ratio | 7.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -327.11 |
Financial Efficiency
Return on equity (ROE) is -73.99% and return on invested capital (ROIC) is -46.02%.
| Return on Equity (ROE) | -73.99% |
| Return on Assets (ROA) | -40.23% |
| Return on Capital (ROIC) | -46.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -486.86M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.44% |
| 50-Day Moving Average | 6,815.80 |
| 200-Day Moving Average | 9,084.50 |
| Relative Strength Index (RSI) | 45.15 |
| Average Volume (20 Days) | 156,124 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.66B |
| Pretax Income | -27.75B |
| Net Income | -27.75B |
| EBITDA | -26.97B |
| EBIT | -28.66B |
| Earnings Per Share (EPS) | -1,010.14 |
Balance Sheet
| Cash & Cash Equivalents | 60.17B |
| Total Debt | n/a |
| Net Cash | 60.17B |
| Net Cash Per Share | 1,791.81 |
| Equity (Book Value) | 57.68B |
| Book Value Per Share | 1,717.52 |
| Working Capital | 54.89B |
Cash Flow
In the last 12 months, operating cash flow was -25.10 billion and capital expenditures -94.70 million, giving a free cash flow of -25.19 billion.
| Operating Cash Flow | -25.10B |
| Capital Expenditures | -94.70M |
| Free Cash Flow | -25.19B |
| FCF Per Share | -750.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 17.66% |
| Shareholder Yield | 17.66% |
| Earnings Yield | -16.37% |
| FCF Yield | -12.16% |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
| Last Split Date | May 13, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |